Clinical Data And Cash: Inflammation Focused InflaRx Hots Up
Positive Phase II data in sepsis and a €31m private financing round: 2016 has been a busy year for inflammation focused German biotech InflaRx.
Positive Phase II data in sepsis and a €31m private financing round: 2016 has been a busy year for inflammation focused German biotech InflaRx.